Design Therapeutics DSGN
$9.02 −$0.30 (-3.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.02 0.00%
Open$9.33
Prev close$9.32
Day range$8.96 – $9.57
Volume281.9K
Market cap$577.61M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts3
Average target$21.67+140.2% vs. price
- Buy 100%
Low $19.00Now $9.02Avg $21.67High $26.00
Recent rating changes
The last 20 actions on file set price targets from $14.00 to $26.00, averaging $19.05.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Piper Sandler | BUY | $20.00 |
| 5 Nov 2026 | RBC Capital | BUY | $19.00 |
| 12 Oct 2026 | Wells Fargo | BUY | $26.00 |
| 2 Oct 2026 | Wells Fargo | BUY | $26.00 |
| 4 Aug 2026 | Craig-Hallum | BUY | $22.00 |
| 3 Aug 2026 | RBC Capital | BUY | $20.00 |
| 15 Jun 2026 | Oppenheimer | BUY | $21.00 |
| 27 May 2026 | Piper Sandler | BUY | $20.00 |
| 19 May 2026 | Craig-Hallum | BUY | $22.00 |
| 18 May 2026 | RBC Capital | BUY | $20.00 |
| 4 May 2026 | Oppenheimer | BUY | $21.00 |
| 29 Apr 2026 | Craig-Hallum | BUY | $15.00 |
| 29 Apr 2026 | Piper Sandler | BUY | $20.00 |
| 28 Apr 2026 | RBC Capital | BUY | $14.00 |
| 15 Mar 2026 | Jefferies | BUY | $15.00 |
| 10 Mar 2026 | Craig-Hallum | BUY | $15.00 |
| 10 Mar 2026 | Oppenheimer | BUY | $18.00 |
| 7 Jan 2026 | Oppenheimer | BUY | $18.00 |
| 3 Dec 2025 | Craig-Hallum | BUY | $15.00 |
| 3 Dec 2025 | Leerink Partners | BUY | $14.00 |
No comments yet — be the first to weigh in on DSGN.
Sign in to join the discussion.